332 related articles for article (PubMed ID: 28288630)
21. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
22. Stathmin, interacting with Nf-κB, promotes tumor growth and predicts poor prognosis of pancreatic cancer.
Lu Y; Liu C; Cheng H; Xu Y; Jiang J; Xu J; Long J; Liu L; Yu X
Curr Mol Med; 2014 Mar; 14(3):328-39. PubMed ID: 24588766
[TBL] [Abstract][Full Text] [Related]
23. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.
Wang X; Deng Y; Mao Z; Ma X; Fan X; Cui L; Qu J; Xie D; Zhang J
Tumour Biol; 2012 Oct; 33(5):1745-58. PubMed ID: 22752926
[TBL] [Abstract][Full Text] [Related]
24. Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
Sato M; Nakanishi K; Haga S; Fujiyoshi M; Baba M; Mino K; ; Niwa H; Yokoo H; Umezawa K; Ohmiya Y; Kamiyama T; Todo S; Taketomi A; Ozaki M
Oncol Res; 2013; 21(6):333-43. PubMed ID: 25198663
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
26. Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment.
Ceylan S; Bahadori F; Akbas F
Pharm Dev Technol; 2020 Sep; 25(7):855-864. PubMed ID: 32188321
[TBL] [Abstract][Full Text] [Related]
27. Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells.
Glorieux C; Huang P
Cancer Commun (Lond); 2019 Jul; 39(1):41. PubMed ID: 31288851
[TBL] [Abstract][Full Text] [Related]
28. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer.
Gong J; Xie J; Bedolla R; Rivas P; Chakravarthy D; Freeman JW; Reddick R; Kopetz S; Peterson A; Wang H; Fischer SM; Kumar AP
Clin Cancer Res; 2014 Mar; 20(5):1259-73. PubMed ID: 24520096
[TBL] [Abstract][Full Text] [Related]
29. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
[TBL] [Abstract][Full Text] [Related]
30. SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-
Xie Y; Li H; Zhong B; Zhu X; Ye R; Xie B; Zhang J
Biomed Res Int; 2023; 2023():7518744. PubMed ID: 36685674
[TBL] [Abstract][Full Text] [Related]
31. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway.
Chen H; Zhang J; Luo J; Lai F; Wang Z; Tong H; Lu D; Bu H; Zhang R; Lin S
Oncol Rep; 2013 Aug; 30(2):589-95. PubMed ID: 23754270
[TBL] [Abstract][Full Text] [Related]
34. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.
Xie C; Liu D; Chen Q; Yang C; Wang B; Wu H
Sci Rep; 2016 Jun; 6():27528. PubMed ID: 27273624
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
36. Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway.
Shi M; He X; Wei W; Wang J; Zhang T; Shen X
Apoptosis; 2015 Jun; 20(6):843-57. PubMed ID: 25690319
[TBL] [Abstract][Full Text] [Related]
37. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
38. NF-κB in pancreatic cancer: Its key role in chemoresistance.
Li Q; Yang G; Feng M; Zheng S; Cao Z; Qiu J; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2018 May; 421():127-134. PubMed ID: 29432846
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer.
Liu A; Shao C; Jin G; Liu R; Hao J; Shao Z; Liu Q; Hu X
Tumour Biol; 2014 Dec; 35(12):12459-65. PubMed ID: 25374060
[TBL] [Abstract][Full Text] [Related]
40. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
